“NMDA-Nitric Oxide-cGMP” pathway modulation in schizophrenia and depression: focus on sodium nitroprusside and ketamine
( Psychiatry and Clinical Psychopharmacology 2013; 23: S14-S15)
( Psychiatry and Clinical Psychopharmacology 2013; 23: S14-S15)
( Psychiatry and Clinical Psychopharmacology 2011; 21: -)